ClassID:

20918

A61K38/1709 - page 6 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#1501
20200123549
2020-04-23

Enhanced organogenesis through manipulation of LIN28/LET-7/DIS3L2

#1502
20200121668
2020-04-23

Use of Hsp70 as a regulator of enzymatic activity

#1503
20200113978
2020-04-16

Pharmaceutical composition and biomaterial comprising fusion peptide in which bone tissue-selective peptide bound to parathyroid hormone (PTH) or fragment thereof

#1504
20200113888
2020-04-16

Use of HSP70 as a regulator of enzymatic activity

#1505
20200113829
2020-04-16

Methods for reducing side effects of immunotherapy

#1506
20200109180
2020-04-09

Anti-tumor properties of Dickkopf 3b

#1507
20200108125
2020-04-09

Methods for the treatment of neurological disorders and diseases using FNDC5

#1508
20200101133
2020-04-02

Methods and compositions for modulation of tau proteins

#1509
20200095297
2020-03-26

Peptides for treatment of diabetes

#1510
20200095286
2020-03-26

Antimicrobial agents and their use in therapy

#1511
20200093924
2020-03-26

Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis

#1512
20200093923
2020-03-26

Compositions and methods for prevention and treatment of hearing loss

#1513
20200087353
2020-03-19

Selective recovery

#1514
20200085917
2020-03-19

Mutant huntingtin-mediated protein dysfunction

#1515
20200085910
2020-03-19

POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF

#1516
20200081007
2020-03-12

Saposin-A derived peptides and uses thereof

#1517
20200079830
2020-03-12

Peptides and compositions for treatment of joint damage

#1518
20200079824
2020-03-12

Gene therapy for tuberous sclerosis

#1519
20200078442
2020-03-12

DPEP-1 binding compositions and methods of use

#1520
20200078441
2020-03-12

Method for blocking stress-induced tumor progression

#1521
20200078299
2020-03-12

Lipid formulations for delivery of messenger RNA

#1522
20200071379
2020-03-05

Uterine cancer treatments

#1523
20200069770
2020-03-05

TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER EYE DISEASES WITH APOLIPOPROTEIN MIMETICS

#1524
20200069769
2020-03-05

Methods of treating inflammatory disorders with multivalent Fc compounds

#1525
20200062812
2020-02-27

NUCLEIC ACID ENCODING GENETICALLY ENGINEERED GROWTH FACTOR VARIANTS

#1526
20200061237
2020-02-27

GILZ formulations for wound healing

#1527
20200061154
2020-02-27

Neuronal survival and axonal regeneration through increasing mitochondrial motility

#1528
20200061153
2020-02-27

Use of vimentin in the modulation of acute inflammation and thrombosis

#1529
20200061094
2020-02-27

Compositions and methods using a polyphenol for musculoskeletal health

#1530
20200055927
2020-02-20

Mast cell stabilizers for treatment of fever

#1531
20200055926
2020-02-20

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

#1532
20200054716
2020-02-20

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TYPE 1 DIABETES USING A BIOLOGIC RESPONSE MODIFIER IN COMBINATION WITH ONE OR MORE ISLET OR BETA CELL REGENERATION OR REPLACEMENT THERAPIES

#1533
20200054711
2020-02-20

REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW

#1534
20200054688
2020-02-20

Method for Precise Identification, Targeting and Delivery of Directed Therapies to Domesticated Animals Using Bacteria to Bind and Destroy Cancerous Cells

#1535
20200054672
2020-02-20

Treatment for periodontitis

#1536
20200054556
2020-02-20

Pegylated liposomal formulations of apelin for treatment of cardiovascular-related diseases

#1537
20200048355
2020-02-13

ALK7 ANTAGONISTS AND USES THEREOF

#1538
20200048344
2020-02-13

Oligonucleotides for reduction of PD-L1 expression

#1539
20200046851
2020-02-13

Gene therapy for retinitis pigmentosa

#1540
20200046816
2020-02-13

Compositions and Methods for Antigen-Specific Tolerance

#1541
20200046725
2020-02-13

Prodrug Comprising a Drug Linker Conjugate

#1542
20200040079
2020-02-06

HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject

#1543
20200038515
2020-02-06

Ice-based lipid nanoparticle formulation for delivery of mRNA

#1544
20200038482
2020-02-06

COMPOSITIONS AND METHODS OF IMPROVED WOUND HEALING

#1545
20200038481
2020-02-06

RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION

#1546
20200038480
2020-02-06

Methods and compositions for TUSC2 immunotherapy

#1547
20200038479
2020-02-06

WOUND HEALING AGENT HAVING ANTIMICROBIAL ACTIVITY AND WOUND HEALING ACCELERATING ACTIVITY

#1548
20200038471
2020-02-06

SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS

#1549
20200038452
2020-02-06

Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases

#1550
20200031905
2020-01-30

Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis

#1551
20200031870
2020-01-30

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1552
20200031869
2020-01-30

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1553
20200031868
2020-01-30

Immunotherapy against several tumors including lung cancer

#1554
20200031867
2020-01-30

Immunotherapy against several tumors including lung cancer

#1555
20200030408
2020-01-30

Methods and compositions for treating Huntington's disease

#1556
20200024668
2020-01-23

Tumor suppressor REC8 as a biomarker for gastric cancer

#1557
20200023083
2020-01-23

METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES

#1558
20200023038
2020-01-23

METHOD OF TREATING NEOPLASIAS

#1559
20200022952
2020-01-23

Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products

#1560
20200022921
2020-01-23

DRY POWDER FORMULATIONS FOR MESSENGER RNA

#1561
20200017590
2020-01-16

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

#1562
20200017563
2020-01-16

Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment

#1563
20200017562
2020-01-16

Methods and compositions for treating neurodegenerative disorders and Alzheimer's Disease and improving normal memory

#1564
20200017560
2020-01-16

CCN3 and CCN3 peptides and analogs thereof for therapeutic use

#1565
20200017551
2020-01-16

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1566
20200016237
2020-01-16

Methods, compounds and compositions for modulating blood brain barrier integrity and re-myelination

#1567
20200016236
2020-01-16

Treatment of age-related macular degeneration

#1568
20200016182
2020-01-16

STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES

#1569
20200010552
2020-01-09

THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS

#1570
20200009237
2020-01-09

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1571
20200009227
2020-01-09

COMPOSITIONS AND METHODS OF CONTROLLING EXPRESSION OF THERMOGENIN (UCP-1) IN SKELETAL MUSCLES

#1572
20200009223
2020-01-09

Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors

#1573
20200009222
2020-01-09

THERAPEUTICALLY ACTIVE COMPLEXES

#1574
20200009221
2020-01-09

METHODS FOR INHIBITING NECROSIS

#1575
20200009220
2020-01-09

Knee pain evaluation and management via WOMAC and KOOS systems

#1576
20200009040
2020-01-09

Topical formulations and methods

#1577
20200002393
2020-01-02

Method of managing joint pain

#1578
20200000882
2020-01-02

Heparin-associated polypeptides and uses thereof

#1579
20200000878
2020-01-02

Therapeutic peptides

#1580
20190390203
2019-12-26

REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS

#1581
20190389948
2019-12-26

Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders

#1582
20190389930
2019-12-26

IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS

#1583
20190388505
2019-12-26

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

#1584
20190388504
2019-12-26

CAPCNA PEPTIDE THERAPEUTICS FOR CANCER

#1585
20190388503
2019-12-26

Formulation, dosage form and method of reducing knee pain

#1586
20190388348
2019-12-26

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES WITH APELIN

#1587
20190381134
2019-12-19

COMPOSITION AND METHOD FOR THE TREATMENT OR PREVENTION OF SPINAL DISORDERS

#1588
20190381132
2019-12-19

METHODS AND COMPOSITIONS FOR TREATMENT OF IONIZING RADIATION RESISTANT TUMORS

#1589
20190380957
2019-12-19

Protein Hydrogels For Treatment Of Neovascular Disease

#1590
20190375810
2019-12-12

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

#1591
20190375807
2019-12-12

Modified ligand-gated ion channels and methods of use

#1592
20190375805
2019-12-12

NAF-1 derived peptides and uses thereof

#1593
20190374604
2019-12-12

Therapeutic compositions

#1594
20190374582
2019-12-12

METHODS AND COMPOSITIONS OF CHONDRISOMES

#1595
20190367577
2019-12-05

Immunoglobulins and uses thereof

#1596
20190367569
2019-12-05

Animal model of longevity and related methods for increasing longevity and inhibiting tumorigenesis

#1597
20190359669
2019-11-28

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1598
20190358297
2019-11-28

ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

#1599
20190358293
2019-11-28

Combination therapy for treating disorders of the ear

#1600
20190358292
2019-11-28

COMPOSITIONS AND METHODS FOR LUNG REGENERATION

#1601
20190358265
2019-11-28

COMPOSITIONS AND METHODS USING AN EPIGENETIC INHIBITOR

#1602
20190358255
2019-11-28

Pharmaceutical composition containing sulglycotide or pharmaceutically acceptable salt thereof for preventing or treating dry eye

#1603
20190352722
2019-11-21

Treatment of angiogenesis disorders

#1604
20190352398
2019-11-21

Combination Immunotherapy For The Treatment of Cancer

#1605
20190352360
2019-11-21

HMGB1 tyrosine mutants

#1606
20190352355
2019-11-21

Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis

#1607
20190352353
2019-11-21

Methods and compositions for delivering interleukin-1 receptor antagonist

#1608
20190345214
2019-11-14

Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

#1609
20190343933
2019-11-14

RNA for treatment or prophylaxis of a liver disease

#1610
20190343922
2019-11-14

HISTATIN FOR CORNEAL WOUND HEALING AND OCULAR SURFACE DISEASE

#1611
20190343921
2019-11-14

WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE

#1612
20190343920
2019-11-14

AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY

#1613
20190343919
2019-11-14

METHODS FOR TREATING PERIPHERAL NERVE INJURY

#1614
20190343916
2019-11-14

Peptides useable for treatment of disorders of the eye

#1615
20190343866
2019-11-14

Nutritional composition with resistant starch useful in the treatment of neoplastic diseases

#1616
20190338361
2019-11-07

Inhibiting the onset of gout

#1617
20190338000
2019-11-07

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1618
20190337999
2019-11-07

Modification and compositions of human secretoglobin proteins

#1619
20190336618
2019-11-07

Intrathecal delivery of recombinant adeno-associated virus 9

#1620
20190336575
2019-11-07

Reversing deficient hedgehog signaling restores deficient skeletal regeneration

#1621
20190336574
2019-11-07

Use of peptides that block metadherin-SND1 interaction as treatment for cancer

#1622
20190336573
2019-11-07

Methods of treating Kawasaki Disease

#1623
20190336566
2019-11-07

METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY

#1624
20190330276
2019-10-31

HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE

#1625
20190328888
2019-10-31

Modified therapeutic agents and compositions thereof

#1626
20190328856
2019-10-31

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1627
20190328847
2019-10-31

Materials and methods useful for treating glioblastoma

#1628
20190328836
2019-10-31

METHODS FOR TREATING ISCHEMIC INJURY

#1629
20190328797
2019-10-31

Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient

#1630
20190328655
2019-10-31

Implantable solid dosage form

#1631
20190322733
2019-10-24

Treatment for Dupuytren's disease

#1632
20190322722
2019-10-24

Immunotherapy against melanoma and other cancers

#1633
20190322721
2019-10-24

Immunotherapy against melanoma and other cancers

#1634
20190322703
2019-10-24

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1635
20190321473
2019-10-24

MINIMALLY-INVASIVE, HIGH RESOLUTION NEUROMODULATION OF DEEP BRAIN AND CORTICAL STRUCTURES USING CIRCUIT-SPECIFIC PROMOTERS AND FOCUSED ULTRASOUND ARRAY

#1636
20190321453
2019-10-24

UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES

#1637
20190321445
2019-10-24

Methods and compositions for modulating myofibroblast activities

#1638
20190321442
2019-10-24

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1639
20190315819
2019-10-17

Peptide directed protein knockdown

#1640
20190314506
2019-10-17

Polymer hydrogels for in vivo applications and methods for using and preparing same

#1641
20190314459
2019-10-17

TREATMENT OF HORMONAL DISORDERS OF GROWTH

#1642
20190314451
2019-10-17

Composition in powder form comprising iron-milk protein complexes and probiotic bacteria

#1643
20190314439
2019-10-17

Method for suppressing obesity or development of obesity

#1644
20190309065
2019-10-10

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

#1645
20190309050
2019-10-10

Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases

#1646
20190309018
2019-10-10

Peptides useable for treating cancer

#1647
20190307892
2019-10-10

TARGETED DRUG DELIVERY AND THERAPEUTIC METHODS USING APO-E MODIFIED LIPID NANOPARTICLES

#1648
20190307865
2019-10-10

Methods for treatment of and prophylaxis against inflammatory disorders

#1649
20190307856
2019-10-10

Arginine and its use as a T cell modulator

#1650
20190307855
2019-10-10

Fibronectin based scaffold domain proteins that bind to myostatin

#1651
20190307842
2019-10-10

Methods for treating bone loss using sclerostin peptides

#1652
20190307834
2019-10-10

Composition for controlled release of therapeutic agents

#1653
20190307832
2019-10-10

Inhibitors of valosin-containing protein and methods of use

#1654
20190307809
2019-10-10

Methods and compositions for in vivo induction of pancreatic beta cell formation

#1655
20190298849
2019-10-03

Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors

#1656
20190298804
2019-10-03

ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS

#1657
20190298800
2019-10-03

Lipoprotein complexes and manufacturing and uses thereof

#1658
20190298799
2019-10-03

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#1659
20190298798
2019-10-03

Trefoil family factor proteins and uses thereof

#1660
20190298781
2019-10-03

Method of reducing the likelihood of skin cancer in an individual human being

#1661
20190298747
2019-10-03

Methods for treatment of cancer by targeting SIRT5

#1662
20190292256
2019-09-26

Compounds and Methods to Measure Metabolic Function and Restore Normal Metabolic Function

#1663
20190292236
2019-09-26

Methods of treating a disorder associated with with insufficient stimulator of interferon genes (STING) activity

#1664
20190292230
2019-09-26

Selective recovery

#1665
20190290810
2019-09-26

Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods

#1666
20190290727
2019-09-26

Immunotherapy against several tumors including gastrointestinal and gastric cancer

#1667
20190290726
2019-09-26

PROTEIN POLYMER FUSIONS FOR SUBCUTANEOUS DELIVERY OF SMALL MOLECULES

#1668
20190282662
2019-09-19

METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY

#1669
20190282660
2019-09-19

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

#1670
20190282659
2019-09-19

Methods of using ZSCAN4 for rejuvenating human cells

#1671
20190282658
2019-09-19

TREATMENT OF EYE DISEASE

#1672
20190282616
2019-09-19

MACROPHAGES REDIRECT PHAGOCYTOSIS BY NON-PROFESSIONAL PHAGOCYTES AND INFLUENCE INFLAMMATION

#1673
20190276517
2019-09-12

Methods and compositions for treating melanoma

#1674
20190275114
2019-09-12

Method for treatment of encephalopathy

#1675
20190271705
2019-09-05

SH2 DOMAIN VARIANTS

#1676
20190270783
2019-09-05

Recombinant lubricin

#1677
20190269798
2019-09-05

Intrathecal delivery of recombinant adeno-associated virus 9

#1678
20190269758
2019-09-05

Methods and compositions for modulating lymphatic vessels in the central nervous system

#1679
20190269756
2019-09-05

CD47 blockade therapy by HDAC inhibitors

#1680
20190269755
2019-09-05

OPTOGENETIC VISUAL RESTORATION USING CHRIMSON

#1681
20190263879
2019-08-29

Immunoglobulins and uses thereof

#1682
20190263876
2019-08-29

Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

#1683
20190262474
2019-08-29

Intrathecal delivery of recombinant adeno-associated virus 9

#1684
20190262422
2019-08-29

HYPOXIA-INDUCED MITOGENIC FACTOR

#1685
20190256846
2019-08-22

Modulation of TJP1 expression to regulate regeneration of heart cells

#1686
20190255146
2019-08-22

POLYPEPTIDES FOR IMPROVED RESPONSE TO ANTI-CANCER THERAPY

#1687
20190255145
2019-08-22

Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases

#1688
20190255144
2019-08-22

SPECIFIC OLIGOPEPTIDES AS ANTI-ANGIOGENIC DRUGS

#1689
20190248853
2019-08-15

Compositions and Methods for Inhibiting Tumor Cells by Inhibiting the Transcription Factor ATF5

#1690
20190247478
2019-08-15

Compositions and methods for treating central nervous system injury

#1691
20190247469
2019-08-15

Nutritional formula

#1692
20190247462
2019-08-15

Use of FKBP-L polypeptides and nucleic acids for the treatment of obesity

#1693
20190246677
2019-08-15

Compositions for the administration of APOA1 and dosages

#1694
20190242909
2019-08-08

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER

#1695
20190241923
2019-08-08

Method for the production of protein complexes and vaccine compositions comprising the same

#1696
20190240292
2019-08-08

METHODS OF ADMINISTERING HEPCIDIN

#1697
20190240289
2019-08-08

Tear lipocalin muteins binding IL-4 r alpha

#1698
20190231848
2019-08-01

POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERS

#1699
20190225986
2019-07-25

GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN

#1700
20190225966
2019-07-25

Treatment for glaucoma and other eye diseases

#1701
20190225664
2019-07-25

ANTAGONISTS OF ACTIVIN-ACTRIIA AND USES FOR INCREASING RED BLOOD CELL LEVELS

#1702
20190225660
2019-07-25

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#1703
20190224277
2019-07-25

BIO-MIMETIC FORMULATION

#1704
20190224124
2019-07-25

Methods and Kits for Reducing the Susceptibility of Lipoprotein Particles to Atherogenic Aggregation Induced by Arterial-Wall Enzymes

#1705
20190218627
2019-07-18

Adeno-associated virus virions with variant capsid

#1706
20190218263
2019-07-18

Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema

#1707
20190218260
2019-07-18

Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells

#1708
20190218254
2019-07-18

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1709
20190216975
2019-07-18

Hemostatic material, preparation method thereof and pharmaceutical composition containing the same

#1710
20190216901
2019-07-18

ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS

#1711
20190216894
2019-07-18

Medical Use of Creg Protein for Prevention or Treatment of Overweight, Obesity and Related Diseases Thereof

#1712
20190216893
2019-07-18

COMPOSITIONS AND METHODS OF MODULATING IMMUNE RESPONSE

#1713
20190216890
2019-07-18

Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance

#1714
20190216884
2019-07-18

Extracellular histones as biomarkers for prognosis and molecular targets for therapy

#1715
20190209648
2019-07-11

ApoO FOR USE IN A METHOD FOR TREATING CANCER AND VARIOUS PATHOPHYSIOLOGICAL SITUATIONS

#1716
20190203210
2019-07-04

Increasing ATOH1 life to drive sensorineural hair cell differentiation

#1717
20190201487
2019-07-04

NNIF and nNIF-related peptides and related methods

#1718
20190201486
2019-07-04

USE OF LIPOSOMAL WNT COMPOSITIONS TO ENHANCE OSSEOINTEGRATION

#1719
20190201484
2019-07-04

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#1720
20190201389
2019-07-04

Heat shock proteins and cholesterol homeostasis

#1721
20190194289
2019-06-27

UTERINE CANCER TREATMENTS

#1722
20190194278
2019-06-27

Immunostimulating peptides

#1723
20190192677
2019-06-27

Conjugate of minoxidil and peptide

#1724
20190192575
2019-06-27

Pathways to Generate Hair Cells

#1725
20190191676
2019-06-27

Use of C1q/TNF-related protein-1 (CTRP1) to treat fatty liver disease

#1726
20190185864
2019-06-20

COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT

#1727
20190185545
2019-06-20

ApoM-Fc fusion proteins, complexes thereof with sphingosine 1-phosphate (S1P), and methods for treating vascular and non-vascular diseases

#1728
20190183977
2019-06-20

Compositions and methods for reducing tumor cell growth at a site of solid tumor excision

#1729
20190183971
2019-06-20

ISCHEMIA/REPERFUSION INJURY

#1730
20190183970
2019-06-20

Methods and compositions for treating Huntington's disease

#1731
20190183932
2019-06-20

Compositions and methods for inhibiting T cell exhaustion

#1732
20190177369
2019-06-13

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1733
20190177368
2019-06-13

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1734
20190175848
2019-06-13

Dry powder inhaler and system for drug delivery

#1735
20190175792
2019-06-13

Implants having a drug load of an oxysterol and methods of use

#1736
20190175763
2019-06-13

Methods and systems for noninvasive control of brain cells and related vectors and compositions

#1737
20190175724
2019-06-13

HYPO-ALLERGENIC CROSS-LINKED PROTEINS FOR USE IN THE PREVENTION OF AN ALLERGY AGAINST MILK-PROTEINS AND FOR USE IN THE INDUCTION OF ORAL TOLERANCE

#1738
20190175690
2019-06-13

COMPOSITIONS AND METHODS FOR CARDIAC REPAIR

#1739
20190175652
2019-06-13

Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosis

#1740
20190170729
2019-06-06

REGULATORY T CELL MEDIATOR PROTEINS AND USES THEREOF

#1741
20190169272
2019-06-06

Removal of serine proteases by treatment with finely divided silicon dioxide

#1742
20190169266
2019-06-06

Constructs having a SIRP-alpha domain or variant thereof

#1743
20190169248
2019-06-06

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

#1744
20190169246
2019-06-06

REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS

#1745
20190169233
2019-06-06

Immunotherapy against several tumors, such as lung cancer, including NSCLC

#1746
20190167767
2019-06-06

Therapeutic combinations to treat red blood cell disorders

#1747
20190167761
2019-06-06

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING STRESS-RELATED DISEASE, INCLUDING DISC1 PROTEIN OR GENE ENCODING THE SAME

#1748
20190167756
2019-06-06

FOXM1 modulators and uses thereof

#1749
20190161527
2019-05-30

Peptides and compositions for treatment of joint damage

#1750
20190161525
2019-05-30

Method for treating Alzheimer's disease and method for downregulating protein aggregation in brain

#1751
20190160158
2019-05-30

C1-INH COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF DISORDERS ASSOCIATED WITH C1 ESTERASE INHIBITOR DEFICIENCY

#1752
20190160157
2019-05-30

C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency

#1753
20190160123
2019-05-30

Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34

#1754
20190153450
2019-05-23

Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides

#1755
20190153056
2019-05-23

Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases

#1756
20190151477
2019-05-23

Intrathecal delivery of recombinant adeno-associated virus 9

#1757
20190151466
2019-05-23

Therapeutic antitumor combination of a TLR4 ligand with other treatments

#1758
20190151417
2019-05-23

Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

#1759
20190151410
2019-05-23

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

#1760
20190151406
2019-05-23

Lipopeptides for use in treating liver diseases and cardiovascular diseases

#1761
20190151312
2019-05-23

HEPARAN SULFATE BIOSYNTHESIS INHIBITORS FOR THE TREATMENT OF DISEASES

#1762
20190144509
2019-05-16

Selective recovery

#1763
20190142969
2019-05-16

ISL1-Based Gene Therapy to Treat Hearing Loss

#1764
20190142900
2019-05-16

Method of treatment of breast or colon cancer by administering muscle stimulated myokines

#1765
20190142898
2019-05-16

Peptides of syndecan-1 for inhibiting angiogenesis

#1766
20190142870
2019-05-16

Enhanced reconstitution and autoreconstitution of the hematopoietic compartment

#1767
20190142862
2019-05-16

Diarrhea-preventing nutritional composition

#1768
20190142746
2019-05-16

Hydrogel toxin-absorbing or binding nanoparticles

#1769
20190135902
2019-05-09

Immunotherapies employing self-assembling vaccines

#1770
20190134230
2019-05-09

Challenge test for diagnosing subtypes of ASD

#1771
20190134229
2019-05-09

Method of identifying ASD phenotype 1 patients

#1772
20190134226
2019-05-09

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#1773
20190134225
2019-05-09

Intrathecal delivery of recombinant Adeno-associated virus 9

#1774
20190134154
2019-05-09

GPNMB compositions for treatment of skin wounds

#1775
20190134152
2019-05-09

Treatment of a subtype of ASD

#1776
20190133144
2019-05-09

Whey preparation for improving brain development

#1777
20190127441
2019-05-02

Methods and compositions for reducing infectivity of virus particles comprising an ERGIC-53 polypeptide

#1778
20190125830
2019-05-02

Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration

#1779
20190125829
2019-05-02

METHOD FOR PREVENTING OBESITY-INDUCED FATTY LIVER BY INHIBITING KCTD17

#1780
20190125828
2019-05-02

Compositions comprising choline

#1781
20190125827
2019-05-02

Lysosomal degradation of lipids and proteins and method of use thereof

#1782
20190125804
2019-05-02

ANTI-CANCER USE OF GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS (HUCPVC)

#1783
20190119341
2019-04-25

Compositions of phosphorylated tau peptides and uses thereof

#1784
20190119295
2019-04-25

COMPOSITIONS AND METHODS FOR TREATING CANCER

#1785
20190117797
2019-04-25

Regenerating functional neurons for treatment of disease in the nervous system

#1786
20190117795
2019-04-25

Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy

#1787
20190117729
2019-04-25

GJA1 isoforms protect against metabolic stress

#1788
20190111152
2019-04-18

Functionalized metal nanoparticle

#1789
20190111135
2019-04-18

Compositions and their use for controlling the nervous system in vivo

#1790
20190105372
2019-04-11

Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema

#1791
20190105371
2019-04-11

USES OF CASEIN COMPOSITIONS

#1792
20190105370
2019-04-11

GLA domains as therapeutic agents

#1793
20190105369
2019-04-11

CD31SHED AGONISTS FOR USE IN THE PREVENTION AND/OR TREATMENT OF REPERFUSION INJURY

#1794
20190099503
2019-04-04

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#1795
20190099468
2019-04-04

METHOD TO PROTECT AND SEAL THE OCULAR SURFACE

#1796
20190094244
2019-03-28

Free Functional Annexin Levels in Plasma as a Biomarker of Cardiovascular Risk

#1797
20190092837
2019-03-28

Prion protein-dendrimer conjugates for use in treatment of alzheimer disease

#1798
20190091312
2019-03-28

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#1799
20190091291
2019-03-28

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE DISORDERS

#1800
20190091154
2019-03-28

HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES